CE Mark Approval for IsoFlow Infusion Catheter

The IsoFlow Infusion Catheter, from Vascular Designs Inc., has received CE Mark approval for use in Europe and Canada. The IsoFlow Infusion Catheter enables targeted sideways perfusion, allowing physicians to precisely target and isolate areas within the body where the infused drugs are delivered. With IsoFlow Infusion Catheter’s unique design, medications can be delivered into areas that could not previously be treated directly, for instance, a cancerous tumor. The device also facilitates the LACE (Lateral Arterial Chemo Embolization) procedure.

“CE Mark approval is an important confirmation of the substantial benefits that patients will receive from targeted treatment of cancerous tumors,” says Robert Goldman, CEO of Vascular Designs Inc. and creator of the IsoFlow Infusion Catheter. “Directing treatment to specific locations increases the number of treatment options allowing better access to tumors and may reduce the discomfort to patients associated with the systemic application of chemotherapy.”

To view an animation illustrating the IsoFlow Infusion Catheter in action and other press materials, please visit http://www.vasculardesigns.com/news.htm.